James Stephen Mccready Mortensen

Direttore Finanziario/CFO presso CHEMRING GROUP PLC

Patrimonio netto: 145 097 $ in data 31/05/2024

45 anni

14 relazioni

Health Technology

Electronic Technology

Consumer Services

Profilo

James Stephen Mccready Mortensen is currently the Chief Financial Officer & Director at Chemring Group Plc since 2024.
He is also a Director at ICU Medical Group Ltd.
Additionally, he completed his undergraduate degree at the University of Bristol.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
CHEMRING GROUP PLC 0.01%	13/12/2023	29 524 ( 0.01% )	145 097 $	31/05/2024

Posizioni attive di James Stephen Mccready Mortensen

Società	Posizione	Inizio
CHEMRING GROUP PLC	Direttore Finanziario/CFO	01/01/2024
ICU Medical Group Ltd. ICU Medical Group Ltd. Medical SpecialtiesHealth Technology Part of ICU Medical, Inc., ICU Medical Group Ltd. is a British company that manufactures specialty medical devices. The company is based in Ashford, UK. JehanZeb Noor has been the CEO of the company since 2019. ICU Medical Group was acquired by ICU Medical, Inc. from Smiths Group Plc on January 06, 2022 for $3,460.41 million.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di James Stephen Mccready Mortensen

Formazione di James Stephen Mccready Mortensen

University of Bristol

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James Stephen Mccready Mortensen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CHEMRING GROUP PLC	Electronic Technology

Aziende private	1
ICU Medical Group Ltd. ICU Medical Group Ltd. Medical SpecialtiesHealth Technology Part of ICU Medical, Inc., ICU Medical Group Ltd. is a British company that manufactures specialty medical devices. The company is based in Ashford, UK. JehanZeb Noor has been the CEO of the company since 2019. ICU Medical Group was acquired by ICU Medical, Inc. from Smiths Group Plc on January 06, 2022 for $3,460.41 million.	Health Technology